Indian Pharmaceuticals & Biotech High Growth Stocks

Aarti Drugs

Market Cap: ₹43.3b

Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.

Granules India

Market Cap: ₹128.2b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.

Strides Pharma Science

Market Cap: ₹65.7b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.

Glenmark Pharmaceuticals

Market Cap: ₹390.8b

Develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America, Europe, and internationally.

Marksans Pharma

Market Cap: ₹114.2b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Caplin Point Laboratories

Market Cap: ₹165.1b

Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.